TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
active
Official procurement procedure

Untargeted metabolomics of cell-free media from suspension-adapted cells producing adeno-associated viruses

Design and execution of research and development
Laboratory services
Research and experimental development services
+1 more
Published value
£180,000
Submission deadline 10 Nov 2022, 12:00 GMT
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: CELL THERAPY CATAPULT LIMITED: "Untargeted metabolomics of cell-free media from suspension-adapted cells producing adeno-associated viruses". Published status: active. Published value: £180,000. 1 published lot. Recorded submission deadline: 10 Nov 2022, 12:00 GMT. See the official notice for participation instructions.
Contracting AuthorityCELL THERAPY CATAPULT LIMITEDScope & CategoriesNot publishedSubmission Window
Closed
10 Nov 2022, 12:00 GMT
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)£180,000
Bidder Intelligence · Authority Profile: CELL THERAPY CATAPULT LIMITED
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for CELL THERAPY CATAPULT LIMITED. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
2.8Bids / Report
0% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 4 active published awards; 4 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityCELL THERAPY CATAPULT LIMITED
Procedure methodNot published
Procurement categoryNot published
Statusactive
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published10 Oct 2022, 11:06 BST
Last source update10 Oct 2022, 11:06 BST
Recurring procurementNo
ClassificationDesign and execution of research and development, Laboratory services, Research and experimental development services, Research laboratory services
Delivery area
OCIDocds-h6vhtk-037448
What is being bought
Cell Therapy Catapult Ltd is seeking through this Open Tender Process to contract with a suitably capable Bidder to provide the Services for the untargeted metabolomics of cell-free media from suspension-adapted cells producing adeno-associated viral vectors (AAV). Briefly, human cells will be subjected to AAV production in parallel with controls. A maximum of 35 sample and two medium controls will be generated in this experiment, designated as "Run 1", and sent to the awarded Bidder each as technical replicates (maximum 3 per sample). The samples will then be processed by the awarded Bidder as per requirements detailed in Specification (Appendix B). In addition to "Run 1", two additional runs ("Run 2" and "Run 3") may be performed at our sole discretion. Importantly, the experimental setup for both "Run 2" and "Run 3" will be similar to that for "Run 1", but sample numbers may differ if additional conditions are included or excluded. A maximum of 37 samples (i.e., including medium controls) will be obtained for either "Run 2" and "Run 3". Subsequent runs or analysis may be performed, contingent on the results obtained from the 3 planned runs. This will be to ensure robustness of the findings or to meet unforeseen project needs. This will be based on satisfactory performance and continued need.
What changed
From the official release history
  1. Published value updated to £180,000
    10 Oct 2022, 11:06 BST
  2. Status changed to active
    10 Oct 2022, 11:06 BST
  3. Official notice release published
    10 Oct 2022, 11:06 BST
  4. Submission deadline changed to 10 Nov 2022, 12:00 GMT
    10 Oct 2022, 11:06 BST
  5. Buyer information updated
    10 Oct 2022, 11:06 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    active
    Published value£180,000
    Cell Therapy Catapult Ltd is seeking through this Open Tender Process to contract with a suitably capable Bidder to provide the Services for the untargeted metabolomics of cell-free media from suspension-adapted cells producing adeno-associated viral vectors (AAV). Briefly, human cells will be subjected to AAV production in parallel with controls. A maximum of 35 sample and two medium controls will be generated in this experiment, designated as "Run 1", and sent to the awarded Bidder each as technical replicates (maximum 3 per sample). The samples will then be processed by the awarded Bidder as per requirements detailed in Specification (Appendix B). In addition to "Run 1", two additional runs ("Run 2" and "Run 3") may be performed at our sole discretion. Importantly, the experimental setup for both "Run 2" and "Run 3" will be similar to that for "Run 1", but sample numbers may differ if additional conditions are included or excluded. A maximum of 37 samples (i.e., including medium controls) will be obtained for either "Run 2" and "Run 3". Subsequent runs or analysis may be performed, contingent on the results obtained from the 3 planned runs. This will be to ensure robustness of the findings or to meet unforeseen project needs. This will be based on satisfactory performance and continued need.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    10 Oct 2022, 11:06 BST
  2. Submission deadline
    10 Nov 2022, 12:00 GMT
Commercial outcome and competition
AwardsNo award published
ContractsNo contract published
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

CELL THERAPY CATAPULT LIMITED

Contracting authority GB-COH-10016023
View buyer profile
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published